ArticleGut2025

Hepatic TM6SF2 activates antitumour immunity to suppress metabolic dysfunction-associated steatotic liver disease-related hepatocellular carcinoma and boosts immunotherapy.

Yating Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.